SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-049657
Filing Date
2022-04-25
Accepted
2022-04-25 16:24:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223704d2_defa14a.htm DEFA14A 17421
2 GRAPHIC tm223704d2_defa14aimg01.jpg GRAPHIC 987429
3 GRAPHIC tm223704d2_defa14aimg02.jpg GRAPHIC 977638
  Complete submission text file 0001104659-22-049657.txt   2724954
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 22849975
SIC: 2834 Pharmaceutical Preparations